These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Evaluation of the Chiou method for determining theophylline dosages. Johnson MH, Burkle WS. Clin Pharm; 1984 Aug; 3(2):174-8. PubMed ID: 6723223 [Abstract] [Full Text] [Related]
6. Comparative pharmacokinetics of theophylline and aminophylline in man. Aslaksen A, Bakke OM, Vigander T. Br J Clin Pharmacol; 1981 Mar; 11(3):269-73. PubMed ID: 7213528 [Abstract] [Full Text] [Related]
8. Rapid prediction of steady-state serum theophylline concentration in patients treated with intravenous aminophylline. Vozeh S, Kewitz G, Wenk M, Follath F. Eur J Clin Pharmacol; 1980 Nov; 18(6):473-7. PubMed ID: 7461015 [Abstract] [Full Text] [Related]
9. Evaluation of three theophylline dosing methods in pediatric patients. Godley PJ, Karboski JA, Godley SE, Edwards GA, Moore ES, Sagraves R. DICP; 1991 Feb; 25(2):179-85. PubMed ID: 2058190 [Abstract] [Full Text] [Related]
10. Enhancement of theophylline clearance by oral activated charcoal. Berlinger WG, Spector R, Goldberg MJ, Johnson GF, Quee CK, Berg MJ. Clin Pharmacol Ther; 1983 Mar; 33(3):351-4. PubMed ID: 6337763 [Abstract] [Full Text] [Related]
11. Accuracy of 11 methods for predicting theophylline dose. Rodvold KA, Paloucek FP, Zell M. Clin Pharm; 1986 May; 5(5):403-8. PubMed ID: 3720210 [Abstract] [Full Text] [Related]
12. Reliability of theophylline clearance in determining chronic oral dosage regimens. Slotfeldt ML, Johnson CE, Grambau G, Weg JG. Am J Hosp Pharm; 1979 Jan; 36(1):66-8. PubMed ID: 758787 [Abstract] [Full Text] [Related]
13. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy. Yamazaki M, Fukutomi O, Kondo N, Kato Z, Nakashima Y, Shinoda S, Agata H, Kondo T, Imaeda N, Orii T. Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380 [Abstract] [Full Text] [Related]
14. Early estimate of theophylline clearance during intravenous infusion. Rizzo A, Mirabella A, Ferrara G, Mangiacavallo A, Bonanno A, Bonsignore G. Eur J Respir Dis; 1986 Apr; 68(4):291-7. PubMed ID: 3732424 [Abstract] [Full Text] [Related]
15. Conversion from intravenous aminophylline to sustained-release theophylline: computer simulation versus in vivo results. Hatton RC, Gotz VP, Robinson JD, Russell WL, Ryerson GG. Clin Pharm; 1983 Apr; 2(4):347-52. PubMed ID: 6883961 [Abstract] [Full Text] [Related]
16. Theophylline elimination in the pregnant and fetal rabbit. Brashear RE, Veng-Pedersen P, Rhodes ML, Smith CN. J Lab Clin Med; 1982 Jul; 100(1):15-25. PubMed ID: 7086267 [Abstract] [Full Text] [Related]
17. Intraindividual changes in theophylline clearance during constant aminophylline infusion in children with acute asthma. Kubo M, Odajima Y, Ishizaki T, Kanagawa S, Yamaguchi M, Nagai T. J Pediatr; 1986 Jun; 108(6):1011-5. PubMed ID: 3712142 [Abstract] [Full Text] [Related]
18. The use of parenteral aminophylline in patients taking slow release theophylline preparations: an observation of clinical practice. Arbab OA, Wiggins J, Ayres JG, Stableforth DE. Br J Dis Chest; 1985 Apr; 79(2):161-71. PubMed ID: 3986120 [Abstract] [Full Text] [Related]
19. Individualized aminophylline therapy in patients with obstructive airway disease: oral dosage prediction from an intravenous test dose. Horai Y, Ishizaki T, Sasaki T, Watanabe M, Kabe J. Eur J Clin Pharmacol; 1982 Apr; 23(2):111-21. PubMed ID: 7140800 [Abstract] [Full Text] [Related]
20. Intravenous aminophylline in patients already taking oral theophylline: effect on calculated dose of knowledge of serum theophylline concentration on admission. Wiggins J, Arbab OA, Stableforth DE, Ayres JG. Thorax; 1986 Oct; 41(10):759-65. PubMed ID: 3538477 [Abstract] [Full Text] [Related] Page: [Next] [New Search]